On the public citation graph
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation
0 signed · 239 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/0471142956.cy1017s53openalex-snapshot
Web‐Based Analysis and Publication of Flow Cytometry Experiments
inferredcites →https://doi.org/10.1002/hep.28459openalex-snapshot
A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation
inferredcites →https://doi.org/10.1002/lt.24845openalex-snapshot
Tolerance after liver transplantation: Where are we?
inferredcites →https://doi.org/10.1007/s00125-016-3917-4openalex-snapshot
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
inferredcites →https://doi.org/10.1016/j.cellimm.2015.02.006openalex-snapshot
Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells
inferredcites →https://doi.org/10.1016/j.clim.2009.06.001openalex-snapshot
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
inferredcites →https://doi.org/10.1016/j.immuni.2019.01.020openalex-snapshot
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
inferredcites →https://doi.org/10.1016/j.jhep.2016.12.017openalex-snapshot
Host conditioning and rejection monitoring in hepatocyte transplantation in humans
inferredcites →https://doi.org/10.1016/j.ymeth.2015.05.008openalex-snapshot
Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data
inferredcites →https://doi.org/10.1038/nbt.1991openalex-snapshot
Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE
inferredcites →https://doi.org/10.1038/nbt.2594openalex-snapshot
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
inferredcites →https://doi.org/10.1038/s41598-018-25574-7openalex-snapshot
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
inferredcites →https://doi.org/10.1073/pnas.1620835114openalex-snapshot
IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors
inferredcites →https://doi.org/10.1097/mot.0000000000000566openalex-snapshot
Taking regulatory T-cell therapy one step further
inferredcites →https://doi.org/10.1097/tp.0000000000001076openalex-snapshot
Predicting Cellular Rejection With a Cell-Based Assay
inferredcites →https://doi.org/10.1097/tp.0b013e31816dd64aopenalex-snapshot
Exhaustive Differentiation of Alloreactive CD8+ T Cells: Critical for Determination of Graft Acceptance or Rejection
inferredcites →https://doi.org/10.1097/tp.0b013e318225276dopenalex-snapshot
Allospecific CD154+ T-Cytotoxic Memory Cells Identify Recipients Experiencing Acute Cellular Rejection After Renal Transplantation
inferredcites →https://doi.org/10.1111/ajt.12509openalex-snapshot
Attenuation of Donor-Reactive T Cells Allows Effective Control of Allograft Rejection Using Regulatory T Cell Therapy
inferredcites →https://doi.org/10.1111/ajt.12934openalex-snapshot
Superiority of Rapamycin Over Tacrolimus in Preserving Nonhuman Primate Treg Half-Life and Phenotype After Adoptive Transfer
inferredcites →https://doi.org/10.1111/ajt.14415openalex-snapshot
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
inferredcites →https://doi.org/10.1111/ajt.15306openalex-snapshot
IL-2 therapy preferentially expands adoptively transferred donor-specific Tregs improving skin allograft survival
inferredcites →https://doi.org/10.1111/ajt.15592openalex-snapshot
Deletion of donor-reactive T cell clones after human liver transplant
inferredcites →https://doi.org/10.1111/ajt.15700openalex-snapshot
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation
inferredcites →https://doi.org/10.1111/j.1399-3046.2011.01617.xopenalex-snapshot
Allospecific CD154 + T‐cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation
inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02459.xopenalex-snapshot
Allospecific CD154+ T Cells Associate with Rejection Risk After Pediatric Liver Transplantation
inferredcites →https://doi.org/10.1126/science.aau2688openalex-snapshot
T reg cells—the next frontier of cell therapy
inferredcites →https://doi.org/10.1126/scitranslmed.aad4134openalex-snapshot
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
inferredcites →https://doi.org/10.1172/jci.insight.123672openalex-snapshot
Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells
inferredcites →https://doi.org/10.1182/blood-2010-07-293795openalex-snapshot
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
inferredcites →https://doi.org/10.1186/2047-1440-2-17openalex-snapshot
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study
inferredcites →https://doi.org/10.18632/oncotarget.6927openalex-snapshot
Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
inferredcites →https://doi.org/10.2337/dc12-0038openalex-snapshot
Administration of CD4+CD25highCD127− Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
inferredcites →https://doi.org/10.2337/dc18-0494openalex-snapshot
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
inferredcites →https://doi.org/10.3389/fimmu.2019.00043openalex-snapshot
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
inferredcites →https://doi.org/10.4049/jimmunol.0903805openalex-snapshot
Regulatory T Cells Require Mammalian Target of Rapamycin Signaling To Maintain Both Homeostasis and Alloantigen-Driven Proliferation in Lymphocyte-Replete Mice
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4835840openalex-extracted
Atheroprotective Human Regulatory T Cells Enhance Cholesterol Efflux by Regulating ABCA1 and PON1 Expression in Macrophages
inferred← citeshttps://doi.org/10.1002/eji.201948131openalex-snapshot
Treg cell therapy: How cell heterogeneity can make the difference
inferred← citeshttps://doi.org/10.1002/eji.202048875openalex-snapshot
Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?
inferred← citeshttps://doi.org/10.1002/eji.202048934openalex-snapshot
Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
inferred← citeshttps://doi.org/10.1002/eji.202451005openalex-snapshot
The Efficiency of Brain‐Derived Neurotrophic Factor Secretion by mRNA‐Electroporated Regulatory T Cells Is Highly Impacted by Their Activation Status
inferred← citeshttps://doi.org/10.1002/eji.70226openalex-snapshot
Tuning the Affinity of Chimeric Antigen Receptors Enhances the Function of Human Engineered Regulatory T Cells
inferred← citeshttps://doi.org/10.1002/jhbp.1077openalex-snapshot
Clinical liver transplant tolerance: Recent topics
inferred← citeshttps://doi.org/10.1002/lt.25948openalex-snapshot
Regulatory T Cell Therapy Following Liver Transplantation
inferred← citeshttps://doi.org/10.1002/mco2.444openalex-snapshot
Role of the immune system in liver transplantation and its implications for therapeutic interventions
inferred← citeshttps://doi.org/10.1002/mco2.669openalex-snapshot
Posttransplant complications: molecular mechanisms and therapeutic interventions
inferred← citeshttps://doi.org/10.1002/stem.3320openalex-snapshot
Combination therapy with Treg and mesenchymal stromal cells enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy
inferred← citeshttps://doi.org/10.1007/s00281-021-00881-wopenalex-snapshot
Functional heterogeneity of CD4+ T cells in liver inflammation
inferred← citeshttps://doi.org/10.1007/s00281-022-00940-wopenalex-snapshot
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease
inferred← citeshttps://doi.org/10.1007/s00467-021-05023-wopenalex-snapshot
Biomarkers of immune tolerance in kidney transplantation: an overview
inferred← citeshttps://doi.org/10.1007/s11894-023-00882-9openalex-snapshot
Current Status of Living Donor Liver Transplantation: Impact, Advantages, and Challenges
inferred← citeshttps://doi.org/10.1007/s12026-026-09811-0openalex-snapshot
Immune cells in liver transplantation: Dual roles, mechanistic insights, and targeted therapeutic strategies
inferred← citeshttps://doi.org/10.1007/s40472-020-00278-yopenalex-snapshot
Recent Progress in Treg Biology and Transplant Therapeutics
inferred← citeshttps://doi.org/10.1007/s40472-025-00489-1openalex-snapshot
Cellular Therapies in Transplantation – Regulatory T Cell Therapies and Virus Specific Therapies
inferred← citeshttps://doi.org/10.1016/b978-0-12-823524-9.00014-9openalex-snapshot
Biliary tree stem cell transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-443-13947-5.00015-4openalex-snapshot
Role of regulatory T cells in pathogenesis and therapeutics of Crohn’s disease and ulcerative colitis
inferred← citeshttps://doi.org/10.1016/b978-0-443-23571-9.00034-7openalex-snapshot
Liver transplantation: the recipient
inferred← citeshttps://doi.org/10.1016/b978-0-443-23571-9.00046-3openalex-snapshot
Strategies to induce tolerance
inferred← citeshttps://doi.org/10.1016/b978-0-7020-8165-1.00089-7openalex-snapshot
Solid Organ Transplantation: Rejection, Immunosuppression, and Tolerance
inferred← citeshttps://doi.org/10.1016/b978-0-7020-8228-3.00014-4openalex-snapshot
Transplantation Pathology
inferred← citeshttps://doi.org/10.1016/j.ajt.2022.09.002openalex-snapshot
Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy
inferred← citeshttps://doi.org/10.1016/j.ajt.2023.01.030openalex-snapshot
Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity
inferred← citeshttps://doi.org/10.1016/j.ajt.2023.06.012openalex-snapshot
Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial
inferred← citeshttps://doi.org/10.1016/j.ajt.2024.09.009openalex-snapshot
Conferring alloantigen specificity to regulatory T cells: A comparative analysis of cell preparations undergoing clinical development in transplantation
inferred← citeshttps://doi.org/10.1016/j.ajt.2024.10.024openalex-snapshot
Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study
inferred← citeshttps://doi.org/10.1016/j.ajt.2025.06.011openalex-snapshot
Mouse orthotopic liver transplantation: Challenges, achievements, and applications
inferred← citeshttps://doi.org/10.1016/j.ajt.2026.03.007openalex-snapshot
Selective impact on regulatory T cells with sustained functional phenotypes by the interleukin-2 mutein VIS171 in a nonhuman primate model
inferred← citeshttps://doi.org/10.1016/j.aohep.2022.100747openalex-snapshot
The translational approach to liver transplantation
inferred← citeshttps://doi.org/10.1016/j.aohep.2022.100760openalex-snapshot
Immunotolerance in liver transplantation: a primer for the clinician
inferred← citeshttps://doi.org/10.1016/j.asjsur.2024.04.094openalex-snapshot
Cell therapies and its derivatives as immunomodulators in vascularized composite allotransplantation
inferred← citeshttps://doi.org/10.1016/j.autrev.2021.102873openalex-snapshot
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials
inferred← citeshttps://doi.org/10.1016/j.bj.2022.01.005openalex-snapshot
Cell therapy in vascularized composite allotransplantation
inferred← citeshttps://doi.org/10.1016/j.bpg.2021.101767openalex-snapshot
Immunosuppression in liver and intestinal transplantation
inferred← citeshttps://doi.org/10.1016/j.bpg.2021.101770openalex-snapshot
Towards tolerance in liver transplantation
inferred← citeshttps://doi.org/10.1016/j.cellimm.2020.104087openalex-snapshot
Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation
inferred← citeshttps://doi.org/10.1016/j.cellimm.2020.104214openalex-snapshot
Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
inferred← citeshttps://doi.org/10.1016/j.cmet.2023.12.019openalex-snapshot
Niche-specific control of tissue function by regulatory T cells—Current challenges and perspectives for targeting metabolic disease
inferred← citeshttps://doi.org/10.1016/j.cyto.2021.155705openalex-snapshot
Cytokines in Liver Transplantation
inferred← citeshttps://doi.org/10.1016/j.dld.2021.08.008openalex-snapshot
Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.177998openalex-snapshot
Visceral adipose tissue regulatory T cells: A potential new target for treating atherosclerosis
inferred← citeshttps://doi.org/10.1016/j.eng.2022.07.007openalex-snapshot
Immunosuppression and Liver Transplantation
inferred← citeshttps://doi.org/10.1016/j.genrep.2023.101782openalex-snapshot
Transplantation immune responses: Biology, challenges, and opportunities using biomaterials
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e33359openalex-snapshot
Computational identification of novel potential genetic pathogenesis and otherwise biomarkers in acute liver allograft rejection
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107669openalex-snapshot
Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109541openalex-snapshot
Dendritic cells originating exosomal miR-193b-3p induces regulatory T cells to alleviate liver transplant rejection
inferred← citeshttps://doi.org/10.1016/j.isci.2025.112515openalex-snapshot
Therapeutic potential of regulatory T cells for stem cell regulation: Insights from Treg-mediated enhancement of limbal stem cell functions
inferred← citeshttps://doi.org/10.1016/j.it.2021.11.001openalex-snapshot
Towards regulatory cellular therapies in solid organ transplantation
inferred← citeshttps://doi.org/10.1016/j.it.2023.04.005openalex-snapshot
Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond
inferred← citeshttps://doi.org/10.1016/j.jaci.2021.11.007openalex-snapshot
Emerging strategies for treating autoimmune disorders with genetically modified Treg cells
inferred← citeshttps://doi.org/10.1016/j.jaci.2023.09.025openalex-snapshot
Regulatory T cells in dominant immunologic tolerance
inferred← citeshttps://doi.org/10.1016/j.jaut.2020.102591openalex-snapshot
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis
inferred← citeshttps://doi.org/10.1016/j.jbiomech.2025.112872openalex-snapshot
The computational fluid dynamics analysis of “left-at-right” liver transplantation: The research from the perspective of biomechanics
inferred← citeshttps://doi.org/10.1016/j.jcyt.2022.06.006openalex-snapshot
Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory T cells
inferred← citeshttps://doi.org/10.1016/j.jhep.2023.01.030openalex-snapshot
Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation
inferred← citeshttps://doi.org/10.1016/j.jhepr.2025.101394openalex-snapshot
Regulatory T cell therapy in autoimmune liver disease and transplantation
inferred← citeshttps://doi.org/10.1016/j.kint.2023.09.021openalex-snapshot
Multiple infusions of ex vivo-expanded regulatory T cells promote CD163+ myeloid cells and kidney allograft survival in non-lymphodepleted non-human primates
inferred← citeshttps://doi.org/10.1016/j.kint.2026.01.005openalex-snapshot
Nobel prize–winning Treg cells in autoimmune kidney diseases and transplantation
inferred← citeshttps://doi.org/10.1016/j.molimm.2025.06.001openalex-snapshot
Trogocytosis-mediated acquisition of MHC class II molecules from plasmacytoid dendritic cells confers donor-specific immune tolerance to CD8+CD45RClow/- regulatory T cells
inferred← citeshttps://doi.org/10.1016/j.omtm.2025.101561openalex-snapshot
HLA-A2 CAR/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function
inferred← citeshttps://doi.org/10.1016/j.stemcr.2023.06.005openalex-snapshot
Cell transplantation-based regenerative medicine in liver diseases
inferred← citeshttps://doi.org/10.1016/j.trim.2022.101540openalex-snapshot
Th17/Treg cell balance in stable liver transplant recipients
inferred← citeshttps://doi.org/10.1016/j.trim.2025.102248openalex-snapshot
Immunosuppression minimization and withdrawal in liver transplantation: The “holy grail”?
inferred← citeshttps://doi.org/10.1016/j.xcrm.2022.100614openalex-snapshot
Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque
inferred← citeshttps://doi.org/10.1016/j.ymthe.2026.03.035openalex-snapshot
Programming precision tolerance: Antigen-gated IL-10 release sharpens CAR-Treg therapy
inferred← citeshttps://doi.org/10.1016/s0140-6736(20)30803-5openalex-snapshot
Kidney transplantation: a safe step forward for regulatory immune cell therapy
inferred← citeshttps://doi.org/10.1038/s41392-026-02910-2openalex-snapshot
Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases
inferred← citeshttps://doi.org/10.1038/s41423-022-00849-2openalex-snapshot
Histone methyltransferase Nsd2 ensures maternal–fetal immune tolerance by promoting regulatory T-cell recruitment
inferred← citeshttps://doi.org/10.1038/s41467-025-64945-3openalex-snapshot
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model
inferred← citeshttps://doi.org/10.1038/s41467-026-71280-8openalex-snapshot
Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I/IIa trial
inferred← citeshttps://doi.org/10.1038/s41575-020-0334-4openalex-snapshot
Understanding, predicting and achieving liver transplant tolerance: from bench to bedside
inferred← citeshttps://doi.org/10.1038/s41590-025-02154-2openalex-snapshot
Regulatory T cell therapies to treat autoimmune diseases and transplant rejection
inferred← citeshttps://doi.org/10.1038/s41598-025-06835-8openalex-snapshot
Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft
inferred← citeshttps://doi.org/10.1038/s42003-021-02237-4openalex-snapshot
Immunological considerations and challenges for regenerative cellular therapies
inferred← citeshttps://doi.org/10.1080/08830185.2025.2531820openalex-snapshot
Immune cells in liver regeneration: Current evidence and potential clinical targets
inferred← citeshttps://doi.org/10.1080/0886022x.2020.1846054openalex-snapshot
Renal allograft surveillance with allospecific T-cytotoxic memory cells
inferred← citeshttps://doi.org/10.1080/15476278.2022.2164159openalex-snapshot
Clinical Manufacturing of Regulatory T Cell Products For Adoptive Cell Therapy and Strategies to Improve Therapeutic Efficacy
inferred← citeshttps://doi.org/10.1080/17474124.2022.2020642openalex-snapshot
The role and function of CD4+ T cells in hepatic ischemia-reperfusion injury
inferred← citeshttps://doi.org/10.1084/jem.20231045openalex-snapshot
First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
inferred← citeshttps://doi.org/10.1093/cei/uxac118openalex-snapshot
The potential for Treg-enhancing therapies in transplantation
inferred← citeshttps://doi.org/10.1097/cld.0000000000000038openalex-snapshot
The potential role of infusions of T regulatory cells in inducing and maintaining liver allograft tolerance
inferred← citeshttps://doi.org/10.1097/mnh.0000000000000737openalex-snapshot
Cellular therapies in kidney transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000003598openalex-snapshot
Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model
inferred← citeshttps://doi.org/10.1097/tp.0000000000003617openalex-snapshot
Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipients
inferred← citeshttps://doi.org/10.1097/tp.0000000000003765openalex-snapshot
Myeloid and Mesenchymal Stem Cell Therapies for Solid Organ Transplant Tolerance
inferred← citeshttps://doi.org/10.1097/tp.0000000000004316openalex-snapshot
Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance
inferred← citeshttps://doi.org/10.1097/tp.0000000000004342openalex-snapshot
Regulatory T Cells: Liquid and Living Precision Medicine for the Future of VCA
inferred← citeshttps://doi.org/10.1097/tp.0000000000004589openalex-snapshot
Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms
inferred← citeshttps://doi.org/10.1097/tp.0000000000005065openalex-snapshot
Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000005220openalex-snapshot
The Critical Role of Regulatory T Cells in Immune Tolerance and Rejection Following Liver Transplantation: Interactions With the Gut Microbiome
inferred← citeshttps://doi.org/10.1097/tp.0000000000005309openalex-snapshot
Regulatory Immune Cell-derived Exosomes: Modes of Action and Therapeutic Potential in Transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000005825openalex-snapshot
Regulatory T Cells Allosensitized Under the Blockade of CD80/CD86-CD28 Costimulation Prolonged Islet Allograft Survival
inferred← citeshttps://doi.org/10.1101/2022.11.10.516049openalex-snapshot
Integration of exogenous and endogenous co-stimulatory signals by CAR-Tregs
inferred← citeshttps://doi.org/10.1101/2023.08.06.551956openalex-snapshot
Matching or genetic engineering of HLA Class I and II facilitates successful allogeneic ‘off-the-shelf’ regulatory T cell therapy
inferred← citeshttps://doi.org/10.1111/ajt.15789openalex-snapshot
Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction
inferred← citeshttps://doi.org/10.1111/ajt.16393openalex-snapshot
Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients
inferred← citeshttps://doi.org/10.1111/ajt.16395openalex-snapshot
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
inferred← citeshttps://doi.org/10.1111/ajt.16740openalex-snapshot
Challenges, highlights, and opportunities in cellular transplantation: A white paper of the current landscape
inferred← citeshttps://doi.org/10.1111/ajt.16842openalex-snapshot
Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade
inferred← citeshttps://doi.org/10.1111/all.14478openalex-snapshot
Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
inferred← citeshttps://doi.org/10.1111/cpr.70033openalex-snapshot
Scalable Matrigel‐Free Suspension Culture for Generating High‐Quality Human Liver Ductal Organoids
inferred← citeshttps://doi.org/10.1111/imm.70151openalex-snapshot
Current Status of Treg Therapy in Transplantation and Autoimmune Disease
inferred← citeshttps://doi.org/10.1111/petr.70260openalex-snapshot
Clinical and Experimental Immune Tolerance in Pediatric Liver Transplantation
inferred← citeshttps://doi.org/10.1111/tan.14591openalex-snapshot
Overcoming barriers to widespread use of CAR‐Treg therapy in organ transplant recipients
inferred← citeshttps://doi.org/10.1111/trf.16797openalex-snapshot
Regulatory T cells: A review of manufacturing and clinical utility
inferred← citeshttps://doi.org/10.1111/tri.13780openalex-snapshot
Cell therapy during machine perfusion
inferred← citeshttps://doi.org/10.1111/tri.13789openalex-snapshot
Cellular therapies in organ transplantation
inferred← citeshttps://doi.org/10.1111/tri.13972openalex-snapshot
T‐ and B‐cell therapy in solid organ transplantation: current evidence and future expectations
inferred← citeshttps://doi.org/10.1126/scitranslmed.adf4287openalex-snapshot
Donor-derived regulatory dendritic cell infusion modulates effector CD8+T cell and NK cell responses after liver transplantation
inferred← citeshttps://doi.org/10.1136/bmjopen-2025-108683openalex-snapshot
Protocol for a phase I single-centre dose escalation trial of autologous thymus derived regulatory T cells in paediatric heart transplant recipients to prevent cardiac allograft vasculopathy (ATT-Heart)
inferred← citeshttps://doi.org/10.1136/flgastro-2020-101425openalex-snapshot
Recent advances in liver transplantation
inferred← citeshttps://doi.org/10.1172/jci.insight.149301openalex-snapshot
Nox2-deficient Tregs improve heart transplant outcomes via their increased graft recruitment and enhanced potency
inferred← citeshttps://doi.org/10.1172/jci.insight.162978openalex-snapshot
Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function
inferred← citeshttps://doi.org/10.1172/jci.insight.167215openalex-snapshot
Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection
inferred← citeshttps://doi.org/10.1182/bloodadvances.2019000965openalex-snapshot
Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells
inferred← citeshttps://doi.org/10.1186/s12882-023-03157-7openalex-snapshot
Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial
inferred← citeshttps://doi.org/10.1186/s12967-021-03200-xopenalex-snapshot
Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product
inferred← citeshttps://doi.org/10.1186/s12967-025-07431-0openalex-snapshot
Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction
inferred← citeshttps://doi.org/10.1210/endrev/bnaa028openalex-snapshot
Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
inferred← citeshttps://doi.org/10.1371/journal.pone.0251601openalex-snapshot
Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model
inferred← citeshttps://doi.org/10.14218/jcth.2022.00194openalex-snapshot
Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors
inferred← citeshttps://doi.org/10.23868/202110003openalex-snapshot
Next-generation immunotherapy: regulatory T-cells
inferred← citeshttps://doi.org/10.23873/2074-0506-2022-14-2-195-209openalex-snapshot
The trend for transplant medicine development: induction of immune tolerance or regulation of immune response?
inferred← citeshttps://doi.org/10.3389/fcell.2020.00317openalex-snapshot
Regulatory T Cell Extracellular Vesicles Modify T-Effector Cell Cytokine Production and Protect Against Human Skin Allograft Damage
inferred← citeshttps://doi.org/10.3389/fcell.2022.1081644openalex-snapshot
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective
inferred← citeshttps://doi.org/10.3389/fcimb.2024.1342354openalex-snapshot
Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenance
inferred← citeshttps://doi.org/10.3389/fgeed.2020.623717openalex-snapshot
Non-immunogenic Induced Pluripotent Stem Cells, a Promising Way Forward for Allogenic Transplantations for Neurological Disorders
inferred← citeshttps://doi.org/10.3389/fimmu.2020.01044openalex-snapshot
Transplant Tolerance Induction: Insights From the Liver
inferred← citeshttps://doi.org/10.3389/fimmu.2020.01227openalex-snapshot
The Human Immune Response to Cadaveric and Living Donor Liver Allografts
inferred← citeshttps://doi.org/10.3389/fimmu.2020.01326openalex-snapshot
Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
inferred← citeshttps://doi.org/10.3389/fimmu.2020.01608openalex-snapshot
The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology
inferred← citeshttps://doi.org/10.3389/fimmu.2020.01723openalex-snapshot
Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives
inferred← citeshttps://doi.org/10.3389/fimmu.2020.02005openalex-snapshot
Metabolic Optimisation of Regulatory T Cells in Transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2020.565518openalex-snapshot
The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
inferred← citeshttps://doi.org/10.3389/fimmu.2020.582939openalex-snapshot
Macrophages in Organ Transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2020.612848openalex-snapshot
Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2021.641596openalex-snapshot
Regulatory Cell Therapy in Organ Transplantation: Achievements and Open Questions
inferred← citeshttps://doi.org/10.3389/fimmu.2021.661875openalex-snapshot
Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2021.662134openalex-snapshot
Targeting Enclysis in Liver Autoimmunity, Transplantation, Viral Infection and Cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2021.664244openalex-snapshot
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
inferred← citeshttps://doi.org/10.3389/fimmu.2021.716606openalex-snapshot
Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects via Adult Progenitor Cell Co-Culture
inferred← citeshttps://doi.org/10.3389/fimmu.2021.719954openalex-snapshot
Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1055466openalex-snapshot
Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2022.746889openalex-snapshot
Utilization of Treg Cells in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2022.863148openalex-snapshot
Editorial: The Spectrum of Treg Subsets in Transplantation: Immune Regulation and Tolerance Induction
inferred← citeshttps://doi.org/10.3389/fimmu.2022.883855openalex-snapshot
Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2022.890019openalex-snapshot
Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis
inferred← citeshttps://doi.org/10.3389/fimmu.2022.969633openalex-snapshot
Costimulation blockade and Tregs in solid organ transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1152742openalex-snapshot
Whole transcriptome analysis reveals that immune infiltration- lncRNAs are related to cellular apoptosis in liver transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1235889openalex-snapshot
Monitoring regulatory T cells as a prognostic marker in lung transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1270300openalex-snapshot
CD4+CD25+FOXP3+ regulatory T cells: a potential “armor” to shield “transplanted allografts” in the war against ischemia reperfusion injury
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1274982openalex-snapshot
Immunologic barriers in liver transplantation: a single-cell analysis of the role of mesenchymal stem cells
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1291649openalex-snapshot
Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1321228openalex-snapshot
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1371089openalex-snapshot
Immune regulation and therapeutic application of T regulatory cells in liver diseases
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1372862openalex-snapshot
Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1444924openalex-snapshot
The potential of autologous regulatory T cell (Treg) therapy to prevent Cardiac Allograft Vasculopathy (CAV) in paediatric heart transplant recipients
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1553533openalex-snapshot
Bronchus-associated lymphoid tissue in lung transplantation: a facilitator of rejection or regulator of tolerance?
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1612360openalex-snapshot
Unlocking the therapeutic potential of thymus-isolated regulatory T cells
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1648926openalex-snapshot
Use of regulatory cells for achieving functional tolerance of pig heart xenotransplants in humans: a literature review
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1654561openalex-snapshot
Regulatory T cell therapy in lung transplantation: bridging the gap from bench to bedside
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1662925openalex-snapshot
Ex vivo expanded human regulatory T cells promote cholesterol efflux and PON1 expression in oxLDL-exposed macrophages via gap junction-mediated cAMP transfer
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1675114openalex-snapshot
Regulatory T cell therapies: from patient data to biological insights
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1685682openalex-snapshot
Regulatory T cell therapy for xenotransplantation, what perspectives?
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1730575openalex-snapshot
Global trends of peripheral immune tolerance research: a bibliometric and visualization analysis
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1762753openalex-snapshot
Regulatory T cells in the era of cell and gene therapy: biology, clinical translation, and future prospects
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1787579openalex-snapshot
The dual role of T cells in solid organ transplant rejection and immune tolerance
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1789008openalex-snapshot
CD25+CD27+CD70− alloantigen-specific Tregs: promising stable immunotherapy for transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1797186openalex-snapshot
Regulatory T cell therapies: biological foundations, engineering strategies, and clinical translation
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1823841openalex-snapshot
Regulatory T cell therapy in solid organ transplantation: mechanisms, translational progress, and remaining barriers
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1908621openalex-snapshot
Advances in nanomaterial-based delivery systems for inducing transplantation tolerance
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1929923openalex-snapshot
Regulatory T cell heterogeneity: who they are, where they come from, and where they go
inferred← citeshttps://doi.org/10.3389/fmed.2020.634260openalex-snapshot
A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001)
inferred← citeshttps://doi.org/10.3389/fnut.2022.869399openalex-snapshot
Innovations in Immunosuppression for Intestinal Transplantation
inferred← citeshttps://doi.org/10.3389/fonc.2023.1167266openalex-snapshot
Umbilical cord blood derived cellular therapy: advances in clinical development
inferred← citeshttps://doi.org/10.3389/fped.2022.862807openalex-snapshot
A New Generation of Cell Therapies Employing Regulatory T Cells (Treg) to Induce Immune Tolerance in Pediatric Transplantation
inferred← citeshttps://doi.org/10.3389/fphar.2020.588436openalex-snapshot
Intrahepatic TH17/TReg Cells in Homeostasis and Disease—It’s All About the Balance
inferred← citeshttps://doi.org/10.3389/ti.2024.13196openalex-snapshot
Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection
inferred← citeshttps://doi.org/10.3390/antib14020049openalex-snapshot
Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?
inferred← citeshttps://doi.org/10.3390/biom14020187openalex-snapshot
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets
inferred← citeshttps://doi.org/10.3390/cancers15245877openalex-snapshot
Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy
inferred← citeshttps://doi.org/10.3390/cells11152327openalex-snapshot
Immunological Tolerance in Liver Transplant Recipients: Putative Involvement of Neuroendocrine-Immune Interactions
inferred← citeshttps://doi.org/10.3390/cells13110959openalex-snapshot
Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?
inferred← citeshttps://doi.org/10.3390/cells14130956openalex-snapshot
Regulatory T Cells Boost Efficacy of Post-Infarction Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cell Transplants
inferred← citeshttps://doi.org/10.3390/ijms22084016openalex-snapshot
Cell-Mediated Therapies to Facilitate Operational Tolerance in Liver Transplantation
inferred← citeshttps://doi.org/10.3390/ijms24021752openalex-snapshot
Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?
inferred← citeshttps://doi.org/10.3390/ijms25094884openalex-snapshot
The Role of Regulatory T Cells and Their Therapeutic Potential in Hypertensive Disease of Pregnancy: A Literature Review
inferred← citeshttps://doi.org/10.3390/immuno3040023openalex-snapshot
Inflammatory Network of Liver Fibrosis and How It Can Be Targeted Therapeutically
inferred← citeshttps://doi.org/10.34133/2022/9826426openalex-snapshot
Programming of Regulatory T Cells In Situ for Nerve Regeneration and Long-Term Patency of Vascular Grafts
inferred← citeshttps://doi.org/10.3748/wjg.v28.i27.3346openalex-snapshot
Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy
inferred← citeshttps://doi.org/10.3748/wjg.v30.i13.1791openalex-snapshot
Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives
inferred← citeshttps://doi.org/10.4049/jimmunol.2200542openalex-snapshot
Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity
inferred← citeshttps://doi.org/10.4110/in.2022.22.e10openalex-snapshot
Recent Advances in Cell Therapeutics for Systemic Autoimmune Diseases
inferred← citeshttps://doi.org/10.4110/in.2023.23.e37openalex-snapshot
Combined Treatment With TGF-β1, Retinoic Acid, and Lactoferrin Robustly Generate Inducible Tregs (iTregs) Against High Affinity Ligand
inferred← citeshttps://doi.org/10.4254/wjh.v16.i11.1225openalex-snapshot
Autoimmune hepatitis: Towards a personalized treatment
inferred← citeshttps://doi.org/10.4285/ctr.24.0029openalex-snapshot
Animal models for transplant immunology: bridging bench to bedside
showing the first 199 of 204 · page through all 204
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.